R.L. Whiting

4.7k total citations
117 papers, 3.4k citations indexed

About

R.L. Whiting is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, R.L. Whiting has authored 117 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 43 papers in Cellular and Molecular Neuroscience and 21 papers in Physiology. Recurrent topics in R.L. Whiting's work include Receptor Mechanisms and Signaling (51 papers), Ion channel regulation and function (32 papers) and Neuropeptides and Animal Physiology (22 papers). R.L. Whiting is often cited by papers focused on Receptor Mechanisms and Signaling (51 papers), Ion channel regulation and function (32 papers) and Neuropeptides and Animal Physiology (22 papers). R.L. Whiting collaborates with scholars based in Poland, United States and United Kingdom. R.L. Whiting's co-authors include Richard M. Eglen, Anton D. Michel, Dana N. Loury, A.D. Michel, Eric Stefanich, Najam A. Sharif, Liron Walsh, Robin D. Clark, William W. Montgomery and J Pybus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

R.L. Whiting

115 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.L. Whiting Poland 34 2.0k 1.5k 737 309 289 117 3.4k
Jan M. Van Nueten Belgium 28 1.3k 0.7× 1.4k 0.9× 758 1.0× 258 0.8× 407 1.4× 65 3.2k
J.W. Black United Kingdom 29 2.2k 1.1× 1.3k 0.9× 551 0.7× 395 1.3× 518 1.8× 87 3.8k
Morton Levitt United States 22 1.7k 0.9× 1.7k 1.1× 1.0k 1.4× 171 0.6× 237 0.8× 52 4.6k
William W. Fleming United States 30 1.6k 0.8× 1.4k 0.9× 1.1k 1.4× 155 0.5× 454 1.6× 131 3.5k
S. Spector United States 32 1.4k 0.7× 1.7k 1.1× 729 1.0× 195 0.6× 265 0.9× 68 3.4k
Norman Kirshner United States 38 2.8k 1.4× 1.6k 1.1× 868 1.2× 368 1.2× 201 0.7× 112 4.7k
S H Snyder United States 24 2.7k 1.3× 2.1k 1.4× 613 0.8× 222 0.7× 134 0.5× 26 4.2k
Keith Bley United States 23 1.7k 0.8× 1.4k 0.9× 1.2k 1.6× 163 0.5× 211 0.7× 39 3.6k
Michael Entzeroth Germany 29 1.5k 0.8× 1.3k 0.8× 401 0.5× 186 0.6× 433 1.5× 52 3.0k
J. Paul Hieble United States 32 2.9k 1.4× 2.0k 1.3× 1.1k 1.5× 317 1.0× 473 1.6× 112 5.1k

Countries citing papers authored by R.L. Whiting

Since Specialization
Citations

This map shows the geographic impact of R.L. Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.L. Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.L. Whiting more than expected).

Fields of papers citing papers by R.L. Whiting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.L. Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.L. Whiting. The network helps show where R.L. Whiting may publish in the future.

Co-authorship network of co-authors of R.L. Whiting

This figure shows the co-authorship network connecting the top 25 collaborators of R.L. Whiting. A scholar is included among the top collaborators of R.L. Whiting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.L. Whiting. R.L. Whiting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreckler, Laura M., Mark A. Osinski, Scott M. Williams, & R.L. Whiting. (2022). Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis. SHILAP Revista de lepidopterología. 5 indexed citations
2.
Schlüter, Philip J., et al.. (2005). Public opinion of a proposed wind farm situated close to a populated area in New Zealand: Results from a cross-sectional study. Environmental Health. 5(3). 73–83. 4 indexed citations
3.
Whiting, R.L., et al.. (2004). The use of sensory difference tests to investigate perceptible colour‐difference in a cosmetic product. Color Research & Application. 29(4). 299–304. 6 indexed citations
4.
Rush, Elaine, et al.. (2003). Hair Zinc Concentrations Not Subject to Seasonal Variation in Adults in New Zealand. Biological Trace Element Research. 95(3). 193–202. 2 indexed citations
5.
Terry, Alvin V., Jerry J. Buccafusco, Mark Prendergast, et al.. (1996). The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. Neuroreport. 8(1). 49–54. 13 indexed citations
6.
7.
Sharif, Najam A., et al.. (1995). M3 muscarinic receptors on murine HSDM1C1 cells: Further functional, regulatory, and receptor binding studies. Neurochemical Research. 20(1). 61–68. 3 indexed citations
8.
Ford, Anthony, Richard M. Eglen, & R.L. Whiting. (1992). Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in guinea pig cardiac muscle. European Journal of Pharmacology Molecular Pharmacology. 225(2). 105–112. 28 indexed citations
9.
Sharif, Naj, et al.. (1991). Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochemical Research. 16(10). 1167–1174. 29 indexed citations
10.
Eglen, Richard M., et al.. (1991). Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea. Naunyn-Schmiedeberg s Archives of Pharmacology. 344(1). 29–35. 9 indexed citations
11.
Craig, Douglas A., et al.. (1990). 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 9–16. 108 indexed citations
12.
Michel, Anton D., et al.. (1990). On the interaction of gallamine with muscarinic receptor subtypes. European Journal of Pharmacology. 182(2). 335–345. 32 indexed citations
13.
14.
Eglen, Richard M., A.D. Michel, & R.L. Whiting. (1989). Characterization of the muscarinic receptor subtype mediating contractions of the guinea‐pig uterus. British Journal of Pharmacology. 96(3). 497–499. 54 indexed citations
15.
Michel, Anton D., et al.. (1989). Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites. British Journal of Pharmacology. 96(2). 457–464. 62 indexed citations
16.
Michel, Anton D. & R.L. Whiting. (1989). Cellular action of nicardipine. The American Journal of Cardiology. 64(15). H3–H7. 20 indexed citations
17.
Eglen, Richard M., et al.. (1988). The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptorsin vitro. British Journal of Pharmacology. 95(4). 1031–1038. 47 indexed citations
18.
Eglen, Richard M., et al.. (1988). Differential effects of pertussis toxin on muscarinic responses in isolated atria and smooth muscle. Journal of Autonomic Pharmacology. 8(1). 29–38. 13 indexed citations
19.
Whiting, R.L.. (1987). Animal pharmacology of nicardipine and its clinical relevance. The American Journal of Cardiology. 59(17). J3–J8. 23 indexed citations
20.
Bowmaker, G.A. & R.L. Whiting. (1976). d10遷移金属錯体における結合 IV いくつかのジハロ金(I)酸錯体の赤外,RamanおよびN.Q.R.による研究. Australian Journal of Chemistry. 29(7). 1407–1412. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan M. Van Nueten Breakdown of academic impact, for papers by J.W. Black Breakdown of academic impact, for papers by Morton Levitt Breakdown of academic impact, for papers by William W. Fleming Breakdown of academic impact, for papers by S. Spector Breakdown of academic impact, for papers by Norman Kirshner Breakdown of academic impact, for papers by S H Snyder Breakdown of academic impact, for papers by Keith Bley Breakdown of academic impact, for papers by Michael Entzeroth Breakdown of academic impact, for papers by J. Paul Hieble
Rankless by CCL
2026